Search

Your search keyword '"Yuen, Sam"' showing total 36 results

Search Constraints

Start Over You searched for: Author "Yuen, Sam" Remove constraint Author: "Yuen, Sam" Search Limiters Full Text Remove constraint Search Limiters: Full Text
36 results on '"Yuen, Sam"'

Search Results

3. Role of stem cell transplant in CD30+ PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

5. Venetoclax-rituximab with or without bendamustine vs bendamustine-rituximab in relapsed/refractory follicular lymphoma

8. Planting a Seed of Experience – Long Term Effects of a Co-curricular Ecogarden-Based Program in Higher Education in Hong Kong

9. Targeting MCL‐1 and BCL‐2 with polatuzumab vedotin and venetoclax overcomes treatment resistance in R/R non‐Hodgkin lymphoma: Results from preclinical models and a Phase Ib study

10. Role of Stem Cell Transplant in CD30+ PTCL Following Frontline Brentuximab Vedotin Plus CHP or CHOP in ECHELON-2.

11. Additional file 2 of Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson���s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial

12. Additional file 1 of Chinese herbal medicine treatment based on subgroup differentiation as adjunct therapy for Parkinson���s disease: study protocol of a pilot add-on, randomised, controlled, pragmatic clinical trial

13. Planting a Seed of Experience – Long Term Effects of a Co-curricular Ecogarden-Based Program in Higher Education in Hong Kong

16. Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) as Frontline Treatment for Patients with CD30-Expressing PERIPHERAL T-Cell Lymphomas (Echelon-2): Impact of Consolidative Stem Cell Transplant

17. The Echelon-2 Trial: 5-Year Results of a Randomized, Double-Blind, Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in Frontline Treatment of Patients with CD30-Positive Peripheral T-Cell Lymphoma

19. Results of a Phase 2, Randomized, Double-Blind Study of Sorafenib Versus Placebo in Combination with Intensive Chemotherapy in Previously Untreated Patients with FLT3-ITD Acute Myeloid Leukemia (ALLG AMLM16)

21. Role of stem cell transplant in CD30+PTCL following frontline brentuximab vedotin plus CHP or CHOP in ECHELON-2

22. Abstract CT133: Targeting BCL-2 and MCL-1 overcomes treatment resistance in relapsed and refractory non-Hodgkin lymphoma: Pre-clinical rationale and results from an open-label phase 1b study

23. An Exploratory Analysis of Brentuximab Vedotin Plus CHP (A+CHP) in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas (ECHELON-2): Impact of Consolidative Stem Cell Transplant

24. Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Updated Analysis of a Phase I/II Study

25. Efficacy and Safety of Venetoclax (Ven) + Rituximab (R) or Ven + Bendamustine (B) + R Randomized Versus B + R in Patients (pts) with Relapsed/Refractory (R/R) Follicular Lymphoma (FL): Final Analysis of Phase II CONTRALTO Study

26. Safety and Efficacy of Atezolizumab in Combination with Rituximab Plus CHOP in Previously Untreated Patients with Diffuse Large B-Cell Lymphoma (DLBCL): Primary Analysis of a Phase I/II Study

27. The ECHELON-2 Trial: Results of a Randomized, Double-Blind, Active-Controlled Phase 3 Study of Brentuximab Vedotin and CHP (A+CHP) Versus CHOP in the Frontline Treatment of Patients with CD30+ Peripheral T-Cell Lymphomas

28. Noise-robust feedforward synchronisation for resource-constrained Gaussian minimum shift keying system in wireless body area network

29. Phase 2 Study of Venetoclax Plus Rituximab or Randomized Ven Plus Bendamustine+Rituximab (BR) Versus BR in Patients with Relapsed/Refractory Follicular Lymphoma: Interim Data

30. Safety and Efficacy of Atezolizumab in Combination with Obinutuzumab and Bendamustine in Patients with Previously Untreated Follicular Lymphoma: An Interim Analysis

31. Sorafenib plus intensive chemotherapy in newly diagnosed FLT3-ITD AML: a randomized, placebo-controlled study by the ALLG

32. Biomineralisation of metals in soil – effect of metal toxicity and precipitation as a protective mechanism

33. Self-healing soil: Biomimetic engineering of geotechnical structures to respond to damage

34. Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

35. Biomineralisation of metals in soil – effect of metal toxicity and precipitation as a protective mechanism

36. Self-healing soil: Biomimetic engineering of geotechnical structures to respond to damage

Catalog

Books, media, physical & digital resources